These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 12133946
1. Priming biologically active antibody responses against an isolated, conformational viral epitope by DNA vaccination. Riedl P, El-Kholy S, Reimann J, Schirmbeck R. J Immunol; 2002 Aug 01; 169(3):1251-60. PubMed ID: 12133946 [Abstract] [Full Text] [Related]
2. Truncated or chimeric endogenous protein antigens gain immunogenicity for B cells by stress protein-facilitated expression. Schirmbeck R, Gerstner O, Reimann J. Eur J Immunol; 1999 May 01; 29(5):1740-9. PubMed ID: 10359129 [Abstract] [Full Text] [Related]
3. Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen. Fomsgaard A, Nielsen HV, Bryder K, Nielsen C, Machuca R, Bruun L, Hansen J, Buus S. Scand J Immunol; 1998 Apr 01; 47(4):289-95. PubMed ID: 9600309 [Abstract] [Full Text] [Related]
4. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent. Wild J, Grusby MJ, Schirmbeck R, Reimann J. J Immunol; 1999 Aug 15; 163(4):1880-7. PubMed ID: 10438922 [Abstract] [Full Text] [Related]
5. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes. Schirmbeck R, Stober D, El-Kholy S, Riedl P, Reimann J. J Immunol; 2002 Jun 15; 168(12):6253-62. PubMed ID: 12055239 [Abstract] [Full Text] [Related]
9. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine. Li X, Yang X, Li L, Liu H, Liu J. Vaccine; 2006 Apr 12; 24(16):3321-31. PubMed ID: 16472546 [Abstract] [Full Text] [Related]
12. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response. Whalen RG, Leclerc C, Dériaud E, Schirmbeck R, Reimann J, Davis HL. Ann N Y Acad Sci; 1995 Nov 27; 772():64-76. PubMed ID: 8546414 [Abstract] [Full Text] [Related]
13. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. Schirmbeck R, Böhm W, Ando K, Chisari FV, Reimann J. J Virol; 1995 Oct 27; 69(10):5929-34. PubMed ID: 7666497 [Abstract] [Full Text] [Related]
15. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12. Schirmbeck R, Reimann J. Intervirology; 2001 Oct 27; 44(2-3):115-23. PubMed ID: 11509872 [Abstract] [Full Text] [Related]